Cargando…

Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy

Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome in native kidney biopsies from adults. In 2009, antibodies to the M-type receptor of phospholipase A2 (anti-PLA2R) were identified in idiopathic MN patients, both within the kidney and in the circulation. The clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaz, Montserrat, Agraz, Irene, Soler, Maria Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Glomerulonephritis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366130/ https://www.ncbi.nlm.nih.gov/pubmed/30747149 http://dx.doi.org/10.1093/ckj/sfy079

Ejemplares similares

Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy
por: Rodas, Lida M, et al.
Publicado: (2018)

The investigative burden of membranous nephropathy in the UK
por: Hamilton, Patrick, et al.
Publicado: (2019)

Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
por: Cheong, Jamie, et al.
Publicado: (2018)

Treatment pattern in patients with idiopathic membranous nephropathy—practices in Sweden at the start of the millennium
por: Lönnbro-Widgren, Jennie, et al.
Publicado: (2016)

Idiopathic membranous nephropathy in patients with diabetes mellitus: a diagnostic and therapeutic quandary!
por: Bhadauria, Dharmendra, et al.
Publicado: (2018)

Necrotizing and crescentic glomerulonephritis with membranous nephropathy in a patient exposed to levamisole-adulterated cocaine
por: Carrara, Camillo, et al.
Publicado: (2016)

Membranous nephropathy due to chronic mercury poisoning from traditional Indian medicines: report of five cases
por: Doshi, Manan, et al.
Publicado: (2018)

Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal
por: Rojas-Rivera, Jorge Enrique, et al.
Publicado: (2019)

Atypical anti-glomerular basement membrane disease
por: Troxell, Megan L., et al.
Publicado: (2016)

IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology
por: Stangou, Maria, et al.
Publicado: (2018)

Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?
por: Selvaskandan, Haresh, et al.
Publicado: (2018)

Study protocol: responding to the needs of patients with IgA nephropathy, a social media approach
por: Graham-Brown, Matthew P M, et al.
Publicado: (2018)

Atypical anti-glomerular basement membrane disease presenting as macroscopic haematuria, loin pain and acute kidney injury after intensive exercise
por: Le Flecher, Arnaud, et al.
Publicado: (2019)

Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy
por: Nguyen, Celine, et al.
Publicado: (2018)

Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome
por: Sandoval, Diego, et al.
Publicado: (2017)

Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis
por: Fernandez-Juarez, Gema, et al.
Publicado: (2016)

Comparing outcomes of biopsy-proven anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis patients treated with cyclophosphamide in the 20th and 21st centuries: a 23-year study
por: Whatmough, Steven, et al.
Publicado: (2018)

Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?
por: Kakajiwala, Aadil, et al.
Publicado: (2016)

Clinical factors influencing the decision to transfuse after percutaneous native kidney biopsy
por: Whittier, William L., et al.
Publicado: (2016)

Minimal change disease onset observed after bevacizumab administration
por: Hanna, Ramy M., et al.
Publicado: (2016)

Post-infectious glomerulonephritis with crescents in adults: a retrospective study
por: Baikunje, Shashidhar, et al.
Publicado: (2016)

Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case series
por: Spartà, Giuseppina, et al.
Publicado: (2018)

Azithromycin suppressed relapses of idiopathic nephrotic syndrome in a child
por: Hara, Hiromichi, et al.
Publicado: (2018)

Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
por: Khalighi, Mazdak A., et al.
Publicado: (2016)

Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis
por: Kittanamongkolchai, Wonngarm, et al.
Publicado: (2016)

Minimal change disease and malaria
por: Rangwani, Neil, et al.
Publicado: (2018)

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome
por: Cortazar, Frank B, et al.
Publicado: (2018)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
por: Lee, Sangho
Publicado: (2018)

Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
por: Stefan, Gabriel, et al.
Publicado: (2022)

WCN23-0542 SARS-COV2 ASSOCIATED MINIMAL CHANGE GLOMERULONEPHRITIS LONG-TERM EFFECTS
por: Akl, A.I., et al.
Publicado: (2023)

Anti-phospholipase A2 Receptor Antibody-Negative Membranous Nephropathy in Pregnancy
por: Saleem, Maryam, et al.
Publicado: (2023)

Recurrent focal segmental glomerulosclerosis apparently resistant to plasmapheresis improves after surgical repair of arteriovenous fistula aneurysms
por: Ding, Yanli, et al.
Publicado: (2016)

Kidney transplant outcomes in familial C3 glomerulopathy
por: Wong, Limy, et al.
Publicado: (2016)

The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: A meta-analysis
por: Wu, Wenli, et al.
Publicado: (2018)

Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
por: Ardalan, Mohammad Reza
Publicado: (2013)

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy
por: Akiyama, Shin’ichi, et al.
Publicado: (2014)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
por: Ardalan, Mohammad-Reza, et al.
Publicado: (2013)

Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
por: Jatem-Escalante, Elias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nfipa23v3ufv9ovdef5hi3u066